Skip to Content

Clinical Trial Detail

ABI-007-MBC-001 tnAcity

Patient Information

A Phase 2/3, Multicenter, Open-Label, Randomized Study of Weekly nab®-Paclitaxel In Combination, Compared To Gemcitabine/Carboplatin, As First Line Negative (Triple Negative) Metastatic Breast Cancer

Study Number
ABI-007-MBC-001

Clinical Trial Categories

  • Breast Cancer - Cancer Control
  • Breast Cancer - Metastatic

Location

  • Cone Health Cancer Center at Alamance Regional
    1236 Huffman Mill Rd.
    Burlington, NC 27215
    Main: 336-538-7725

Directions

Large Conference Room: Please enter the building through the door to the right of the main entranceā€¦this door is a direct entrance to our meeting room. The Valet service is operating at our main entrance for our patients.

Also in this Section